Patents by Inventor Giancarlo Carpanese

Giancarlo Carpanese has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Process for the purification of hyaluronic acid
    Patent number: 11198742
    Abstract: A process is described for the purification of HA, and pharmaceutical, cosmetic and nutritional compositions containing HA thus purified.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: December 14, 2021
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza Corsa, Giancarlo Carpanese
  • Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
    Patent number: 10821131
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Grant
    Filed: April 17, 2017
    Date of Patent: November 3, 2020
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Anna Maria Zanellato, Vincenza Corsa, Giancarlo Carpanese, Monica Campisi
  • PROCESS FOR THE PURIFICATION OF HYALURONIC ACID
    Publication number: 20190023813
    Abstract: A process is described for the purification of HA, and pharmaceutical, cosmetic and nutritional compositions containing HA thus purified.
    Type: Application
    Filed: July 17, 2018
    Publication date: January 24, 2019
    Applicant: FIDIA FARMACEUTICI S.P.A.
    Inventors: Vincenza CORSA, Giancarlo CARPANESE
  • PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES
    Publication number: 20170216344
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Application
    Filed: April 17, 2017
    Publication date: August 3, 2017
    Applicant: FIDIA FARMACEUTICI S.p.A.
    Inventors: Anna Maria ZANELLATO, Vincenza CORSA, Giancarlo CARPANESE, Monica CAMPISI
  • Pharmaceutical formulations comprising chondroitin sulfate and hyaluronic acid derivatives
    Patent number: 9655918
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: May 23, 2017
    Assignee: FIDIA FARMACEUTICI S.P.A.
    Inventors: Anna Maria Zanellato, Vincenza Corsa, Giancarlo Carpanese, Monica Campisi
  • PHARMACEUTICAL FORMULATIONS COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID DERIVATIVES
    Publication number: 20150072954
    Abstract: The present invention relates to pharmaceutical formulations containing a combination of specific high-molecular weight hyaluronic acid derivatives and chondroitin sulfate to be used in the treatment of osteoarthritis, of subchondral damage, osteoporosis, synovitis, tenosynovitis, tendinitis, tendinosis, as an intra-articular washing liquid and as a viscous substitute of synovial fluid following osteochondral surgery. These formulations are also suitable for the treatment of interstitial cystitis.
    Type: Application
    Filed: March 27, 2013
    Publication date: March 12, 2015
    Applicant: FIDIA FARMACEUTICI S.p.A.
    Inventors: Anna Maria Zanellato, Vincenza Corsa, Giancarlo Carpanese, Monica Campisi